Delivery Order SPE2DB20D2002-SPE2DB25FL58M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,668.94 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Priorix vials with a completion deadline of August 4, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $18,169.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Priorix vials with a completion date of July 24, 2025. This competitively awarded, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a $1,755.30 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Priorix vials, a measles, mumps, and rubella vaccine product. This firm fixed-price contract, with a completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a $80,289.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials. This competitively awarded, non-set-aside contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella (MMR) vaccine used across military and federal healthcare systems. This...
- The Defense Logistics Agency awarded a $13,861.68 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Priorix vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $24,753.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Priorix vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $4,368.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the procurement of Priorix vials, with a completion date of June 25, 2025. This non-set-aside award was competitively issued and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella vaccine commonly used by military and federal healthcare systems to maintain immunization readiness across the Department of Defense....
- The Defense Logistics Agency (DLA) awarded a $14,845.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of June 10, 2025. This is a non-set-aside competitive award executed on June 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials, valued at $1,009.42, with an ultimate completion date of June 2, 2025. This is a firm fixed-price delivery order issued under a competitive procurement process with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,514.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at the contractor's location in Conshohocken,...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL58MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Priorix vials, valued at $35,329.70. This firm fixed-price delivery order, which is expected to be completed by July 23, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. Priorix is a measles, mumps, and rubella (MMR) vaccine commonly used in military and federal healthcare systems for immunization programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal medical vendor through its extensive portfolio of vaccine and pharmaceutical product deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's selection under the DLA's prime vendor program reflects its capability to meet federal procurement requirements for essential medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.3k | 7/22/25 |